Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
SEK 0.54
Key Takeaways
Risk factor
Very high price volatility
Data is available to registered users only
Data is available to registered users only
Profitability factor
Very favourable analyst view
Data is available to registered users only
Data is available to registered users only
About
BrainCool AB (publ), a medical device company, together with its subsidiaries, engages in the development, marketing, and sale of medical cooling systems for the healthcare sector in Sweden. The company offers products for medical cooling treatments for a range of diseases, including stroke, sudden cardiac arrest, oral mucositis, and migraine. It provides BrainCool and RhinoChill...
Company Valuation
Based on key historical and expected multiples, the stock is undervalued relative to its peers.
Data is available to registered users only
Target Price
The average target price of BRAIN.ST is 1.00 and suggests 86% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to in
Data is available to registered users only
Buy
Sell